SCHEMBL24865657

SCHEMBL24865657

CC1CCN(c2ccc(Nc3ccc4c(=O)n(C)n(C)c4c3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
USP2 O75604 1/20 0.41
MCL1 Q07820 1/20 0.40
SHMT2 P34897 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
MAPT P10636 4/20 0.38
GAA P10253 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK1 P28482 2/20 0.38
POLB P06746 1/20 0.38
ADRA2A P08913 3/20 0.36
ADRA2B P18089 3/20 0.36
ADRA2C P18825 3/20 0.36
KDM4E B2RXH2 1/20 0.36
RAD52 P43351 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865749 0.86 BCL6 (0.39) MAPTADRA2AADRA2BADRA2CKDM4E
SCHEMBL29208991 0.81 GPR119 (0.43) SMN1; SMN2NPC1RAB9ALMNAUSP2
SCHEMBL24865209 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL30336497 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL24865221 0.79 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL31123236 0.76 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL24865216 0.76 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL24865638 0.75 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL24865664 0.75 EGFR (0.53) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL30336115 0.75 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 SMN1; SMN2 1657/4885NPC1 237/4885RAB9A 1785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.